Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-081594

Chief Business Officer sold 11,000 shares at $32.49 ($357,390)

  • Chief Business Officer acquired 11,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2024-07-01 Option exercise 10b5-1 +11,000 $3.29 $36,190 37,291 D
Robb Gary Charles Chief Business Officer 2024-07-01 Sale 10b5-1 −11,000 $32.49 $357,390 26,291 D
Derivatives
Robb Gary Charles Chief Business Officer 2024-07-01 Option exercise · Stock option (right to buy) 10b5-1 −11,000 25,037 D
Open-market sales · 11,000 sh · avg $32.49 · $357,390
Loading xslF345X05/ownership.xml…